Craig C. Phillips has been appointed as vice president and general manager of the Oncology Business Unit of
Cephalon. In this role, Mr. Phillips will have responsibility for managing all aspects of the U.S. oncology business including sales, marketing and medical affairs.
"Since joining Cephalon two years ago, Craig has clearly demonstrated an ability to exceed expectations and bring value to our organization through his leadership," said Robert Roche, Cephalon's executive vice president, Worldwide Pharmaceutical Operations. "I am confident that Craig's leadership and vision will support the dynamic growth of the Cephalon Oncology business and allow us to continue to bring medicines that matter to the healthcare professionals and patients battling cancer."
Mr. Phillips joined Cephalon in 2007 as senior group director of sales, national accounts and sales training for the Oncology Business Unit. Under his leadership, the sales team was instrumental in 2008 for the successful U.S. introduction of two indications for Treanda for Injection, the most recent addition to the company's Oncology portfolio. Prior to joining Cephalon, he spent 15 years at Johnson & Johnson and has more than 22 years of pharmaceutical industry experience.
Sign up today for Contracting & Outsourcing 2009!
Magazine
